SynCore Biotechnology Co Ltd Long-term Investment Intensity
SynCore Biotechnology Co Ltd long-term investment intensity. SynCore Biotechnology Co Ltd (4192) has a Long-term Investment Intensity of 4.0% as of December 2019. Long-term investments of NT$30.39 Million represent 4.0% of total assets of NT$763.88 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read SynCore Biotechnology Co Ltd (4192) financial obligations for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of SynCore Biotechnology Co Ltd (2015–2019)
Long-term investment intensity of SynCore Biotechnology Co Ltd from 2015 to 2019. This chart shows how SynCore Biotechnology Co Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2015 to 2019. As of December 2019, the intensity stands at 4.0%, reflecting long-term investments of NT$30.39 Million against total assets of NT$763.88 Million TWD.
SynCore Biotechnology Co Ltd Long-term Investment Intensity by Year (2015–2019)
SynCore Biotechnology Co Ltd long-term investment intensity by year from 2015 to 2019. The table below presents the year-by-year Long-term Investment Intensity for SynCore Biotechnology Co Ltd from 2015 to 2019, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of SynCore Biotechnology Co Ltd.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 4.0% | NT$30.39 Million | NT$763.88 Million | ▼ -3.3 pp |
| 2018 | 7.3% | NT$58.87 Million | NT$804.80 Million | ▼ -4.8 pp |
| 2017 | 12.1% | NT$102.65 Million | NT$845.89 Million | ▲ +4.0 pp |
| 2016 | 8.1% | NT$90.44 Million | NT$1.11 Billion | ▼ -15.1 pp |
| 2015 | 23.2% | NT$238.34 Million | NT$1.03 Billion | — |